Antiplasmodial properties of acyl-lysyl oligomers in culture and animal models of malaria

Antimicrobial Agents and Chemotherapy

Volumn 55, Issue 8, 2011, Pages 3803-3811

  Zaknoon, Fadia ^a   Wein, Sharon ^b   Krugliak, Miriam ^c   Meir, Ohad ^a   Rotem, Shahar ^a   Ginsburg, Hagai ^c   Vial, Henri ^b   Mor, Amram ^a  

^a TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

^b UNIVERSITÉ DE MONTPELLIER   (France)

^c HEBREW UNIVERSITY OF JERUSALEM   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMALARIAL AGENT; DODECANOYLLYSYLBIS(AMINOOCTANOYLLYSYL)AMIDE; OLIGOMER; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIMALARIAL ACTIVITY; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG ACCUMULATION; DRUG BLOOD LEVEL; DRUG DESIGN; DRUG EFFICACY; DRUG ELIMINATION; DRUG MECHANISM; DRUG MEGADOSE; DRUG POTENCY; DRUG SCREENING; ERYTHROCYTE; FEMALE; HEMOLYSIS; HUMAN; HUMAN CELL; IC 50; MALARIA; MALE; MOUSE; NONHUMAN; PARASITEMIA; PLASMODIUM FALCIPARUM; PLASMODIUM VINCKEI; PRIORITY JOURNAL; STRUCTURE ACTIVITY RELATION; TROPHOZOITE;

ANIMALS; ANTIMALARIALS; DISEASE MODELS, ANIMAL; DRUG DISCOVERY; ERYTHROCYTES; HEMOLYSIS; MALARIA; MALE; MICE; MICE, INBRED ICR; MOLECULAR STRUCTURE; OLIGOPEPTIDES; PARASITIC SENSITIVITY TESTS; PLASMODIUM FALCIPARUM;

EID: 79960291552     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.00129-11     Document Type: Article

References (54)

1. Barkan, D., H. Ginsburg, and J. Golenser. 2000. Optimisation of flow cytometric measurement of parasitaemia in plasmodium-infected mice. Int. J. Parasitol. 30:649-653.
2. Brogden, K. A. 2005. Antimicrobial peptides: pore formers or metabolic inhibitors in bacteria? Nat. Rev. Microbiol. 3:238-250.
3. Brown, K. L., and R. E. Hancock. 2006. Cationic host defense (antimicrobial) peptides. Curr. Opin. Immunol. 18:24-30.
4. Chen, Y., et al. 2005. Rational design of alpha-helical antimicrobial peptides with enhanced activities and specificity/therapeutic index. J. Biol. Chem. 280:12316-12329.
5. Efron, L., A. Dagan, L. Gaidukov, H. Ginsburg, and A. Mor. 2002. Direct interaction of dermaseptin S4 aminoheptanoyl derivative with intraerythrocytic malaria parasite leading to increased specific antiparasitic activity in culture. J. Biol. Chem. 277:24067-24072.
6. Epand, R. F., H. Sarig, A. Mor, and R. M. Epand. 2009. Cell-wall interactions and the selective bacteriostatic activity of a miniature oligo-acyl-lysyl. Biophys. J. 97:2250-2257.
7. Epand, R. M., S. Rotem, A. Mor, B. Berno, and R. F. Epand. 2008. Bacterial membranes as predictors of antimicrobial potency. J. Am. Chem. Soc. 130: 14346-14352.
8. Evans, C. G., L. Chang, and J. E. Gestwicki. 2010. Heat shock protein 70 (Hsp70) as an emerging drug target. J. Medicin. Chem. 53:4585-4602.
9. Feder, R., A. Dagan, and A. Mor. 2000. Structure-activity relationship study of antimicrobial dermaseptin S4 showing the consequences of peptide oligomerization on selective cytotoxicity. J. Biol. Chem. 275:4230-4238.
10. Frecer, V., B. Ho, and J. L. Ding. 2004. De novo design of potent antimicrobial peptides. Antimicrob. Agents Chemother. 48:3349-3357.
11. Ganz, T., and R. I. Lehrer. 1999. Antibiotic peptides from higher eukaryotes: biology and applications. Mol. Med. Today 5:292-297.
12. Gordon, Y. J., E. G. Romanowski, and A. M. McDermott. 2005. A review of antimicrobial peptides and their therapeutic potential as anti-infective drugs. Curr. Eye Res. 30:505-515.
13. Greenwood, B. M., et al. 2008. Malaria: progress, perils, and prospects for eradication. J. Clin. Invest. 118:1266-1276.
14. Gwadz, R. W., et al. 1989. Effects of magainins and cecropins on the sporogonic development of malaria parasites in mosquitoes. Infect. Immun. 57: 2628-2633.
15. Held-Kuznetsov, V., S. Rotem, Y. G. Assaraf, and A. Mor. 2009. Host-defense peptide mimicry for novel antitumor agents. FASEB J. 23:4299-4307.
16. Jaynes, J. M., et al. 1988. In vitro cytocidal effect of novel lytic peptides on Plasmodium falciparum and Trypanosoma cruzi. FASEB J. 2:2878-2883.
17. Kluver, E., et al. 2005. Structure-activity relation of human beta-defensin 3: influence of disulfide bonds and cysteine substitution on antimicrobial activity and cytotoxicity. Biochemistry 44:9804-9816. (Pubitemid 40994374)
18. Krugliak, M., et al. 2000. Antimalarial activities of dermaseptin S4 derivatives. Antimicrob. Agents Chemother. 44:2442-2451.
19. Kustanovich, I., D. E. Shalev, M. Mikhlin, L. Gaidukov, and A. Mor. 2002. Structural requirements for potent versus selective cytotoxicity for antimicrobial dermaseptin S4 derivatives. J. Biol. Chem. 277:16941-16951.
20. Kutner, S., W. V. Breuer, H. Ginsburg, S. B. Aley, and Z. I. Cabantchik. 1985. Characterization of permeation pathways in the plasma membrane of human erythrocytes infected with early stages of Plasmodium falciparum: association with parasite development. J. Cell. Physiol. 125:521-527.
21. Lambros, C., and J. P. Vanderberg. 1979. Synchronization of Plasmodium falciparum erythrocytic stages in culture. J. Parasitol. 65:418-420.
22. Lehrer, R. I., and T. Ganz. 1999. Antimicrobial peptides in mammalian and insect host defence. Curr. Opin. Immunol. 11:23-27.
23. Levy, O. 2000. Antimicrobial proteins and peptides of blood: templates for novel antimicrobial agents. Blood 96:2664-2672.
24. Livne, L., R. F. Epand, B. Papahadjopoulos-Sternberg, R. M. Epand, and A. Mor. 2010. OAK-based cochleates as a novel approach to overcome multi-drug resistance in bacteria. FASEB J. 24:5092-5101.
25. Livne, L., et al. 2009. Design and characterization of a broad-spectrum bactericidal acyl-lysyl oligomer. Chem. Biol. 16:1250-1258.
26. Lohner, K., and S. E. Blondelle. 2005. Molecular mechanisms of membrane perturbation by antimicrobial peptides and the use of biophysical studies in the design of novel peptide antibiotics. Comb. Chem. High Throughput Screen. 8:241-256.
27. Matsuzaki, K. 1999. Why and how are peptide-lipid interactions utilized for self-defense? Magainins and tachyplesins as archetypes. Biochim. Biophys. Acta 1462:1-10.
28. Matsuzaki, K., K. Sugishita, N. Fujii, and K. Miyajima. 1995. Molecular basis for membrane selectivity of an antimicrobial peptide, magainin 2. Biochemistry 34:3423-3429.
29. Mor, A. 2009. Multifunctional host defense peptides: antiparasitic activities. FEBS J. 276:6474-6482.
30. Navon-Venezia, S., R. Feder, L. Gaidukov, Y. Carmeli, and A. Mor. 2002. Antibacterial properties of dermaseptin S4 derivatives with in vivo activity. Antimicrob. Agents Chemother. 46:689-694.
31. Nicolas, P. 2009. Multifunctional host defense peptides: intracellular-targeting antimicrobial peptides. FEBS J. 276:6483-6496.
32. Nicolas, P., and A. Mor. 1995. Peptides as weapons against microorganisms in the chemical defense system of vertebrates. Annu. Rev. Microbiol. 49: 277-304.
33. Otvos, L., et al. 2000. Interaction between heat shock proteins and antimicrobial peptides. Biochemistry 39:14150-14159.
34. Perron, G. G., M. Zasloff, and G. Bell. 2006. Experimental evolution of resistance to an antimicrobial peptide. Proc. Biol. Sci. 273:251-256.
35. Peschel, A., and H. G. Sahl. 2006. The co-evolution of host cationic antimicrobial peptides and microbial resistance. Nat. Rev. Microbiol. 4:529-536.
36. Porter, E. A., X. Wang, H. S. Lee, B. Weisblum, and S. H. Gellman. 2000. Non-haemolytic beta-amino-acid oligomers. Nature 404:565.
37. Radzishevsky, I., M. Krugliak, H. Ginsburg, and A. Mor. 2007. Antiplasmodial activity of lauryl-lysine oligomers. Antimicrob. Agents Chemother. 51: 1753-1759.
38. Radzishevsky, I. S., et al. 2008. Structure-activity relationships of antibacterial acyl-lysine oligomers. Chem. Biol. 15:354-362.
39. Radzishevsky, I. S., et al. 2007. Improved antimicrobial peptides based on acyl-lysine oligomers. Nat. Biotechnol. 25:657-659.
40. Rautenbach, M., N. M. Vlok, M. Stander, and H. C. Hoppe. 2007. Inhibition of malaria parasite blood stages by tyrocidines, membrane-active cyclic peptide antibiotics from Bacillus brevis. Biochim. Biophys. Acta 1768:1488-1497.
41. Rotem, S., and A. Mor. 2009. Antimicrobial peptide mimics for improved therapeutic properties. Biochim. Biophys. Acta 1788:1582-1592.
42. Rotem, S., et al. 2008. Analogous oligo-acyl-lysines with distinct antibacterial mechanisms. FASEB J. 22:2652-2661.
43. Sarig, H., Y. Goldfeder, S. Rotem, and A. Mor. 2011. Mechanisms mediating bactericidal properties and conditions that enhance the potency of a broad-spectrum oligo-acyl-lysyl. Antimicrob. Agents Chemother. 55:688-695.
44. Sarig, H., et al. 2010. A miniature mimic of host defense peptides with systemic antibacterial efficacy. FASEB J. 24:1904-1913.
45. Shai, Y. 1999. Mechanism of the binding, insertion and destabilization of phospholipid bilayer membranes by alpha-helical antimicrobial and cell non-selective membrane-lytic peptides. Biochim. Biophys. Acta 1462:55-70.
46. Snow, R. W., C. A. Guerra, A. M. Noor, H. Y. Myint, and S. I. Hay. 2005. The global distribution of clinical episodes of Plasmodium falciparum malaria. Nature 434:214-217.
47. Tossi, A., L. Sandri, and A. Giangaspero. 2000. Amphipathic, alpha-helical antimicrobial peptides. Biopolymers 55:4-30.
48. Tossi, A., et al. 1997. An approach combining rapid cDNA amplification and chemical synthesis for the identification of novel, cathelicidin-derived, antimicrobial peptides. Methods Mol. Biol. 78:133-150.
49. Vizioli, J., et al. 2001. Gambicin: a novel immune responsive antimicrobial peptide from the malaria vector Anopheles gambiae. Proc. Natl. Acad. Sci. U. S. A. 98:12630-12635.
50. Wade, D., et al. 1990. All-D amino acid-containing channel-forming antibiotic peptides. Proc. Natl. Acad. Sci. U. S. A. 87:4761-4765.
51. Yang, L., T. M. Weiss, R. I. Lehrer, and H. W. Huang. 2000. Crystallization of antimicrobial pores in membranes: magainin and protegrin. Biophys. J. 79:2002-2009.
52. Yeaman, M. R., and N. Y. Yount. 2003. Mechanisms of antimicrobial peptide action and resistance. Pharmacol. Rev. 55:27-55.
53. Zaknoon, F., et al. 2009. Antibacterial properties and mode of action of a short acyl-lysyl oligomer. Antimicrob. Agents Chemother. 53:3422-3429.
54. Zasloff, M. 2002. Antimicrobial peptides of multicellular organisms. Nature 415:389-395. (Pubitemid 34100944)